menu toggle
Friday, November 28
Our offices will also be closed on Friday, November 28. While some deliveries will take place on Friday according to network operations, our Customer Service and Customer Systems Support teams will be unavailable. Please review our full holiday schedule for more detailed information and to plan your orders accordingly.
Action required: New logo and email address for invoices starting October 18
Ensure that you’re prepared to continue receiving invoices electronically.

April 14, 2023

Now available ALTUVIIIO™

ALTUVIIIO™ [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl] is a recombinant DNA-derived, Factor VIII concentrate indicated for use in adults and children with hemophilia A (congenital factor VIII deficiency) for:
- Routine prophylaxis to reduce the frequency of bleeding episodes
- On-demand treatment & control of bleeding episodes
- Perioperative management of bleeding 
 
Limitation of Use:
ALTUVIIIO is not indicated for the treatment of von Willebrand disease.

 

Please see full prescribing information here.